GILEAD SCIENCES, INC. — Director's Dealing 2019

Apr 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-04-17

Reporting Person: Cogan John Francis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-17	Common Stock	M	2700	$22.015	Acquired	57560	Direct
2019-04-17	Common Stock	S	2600	$64.2145	Disposed	54960	Direct
2019-04-17	Common Stock	S	100	$64.66	Disposed	54860	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-17	Non-qualified Stock Option (Right to Buy)	$22.015	M	2700	Disposed	2019-05-06	Common Stock (2700)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Sale prices reported for the transactions reported here range from $63.65 to $64.63. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F3: The options vested quarterly over the first year of service and were fully vested on May 6, 2010.